References
- Selby McElwain P. J., Nandi T. J., Perren A. C., Powles T. J., Tillyer R. L., Osborne C. R., Slevin R. J.M.L., Malpas J. S. Multiple myeloma treated with high dose intravenous melphalan. British Journal of Haematology 1987; 66: 55–62
- Selby Zulian P. J., Forgeson G., Nandi G, Milan A., Meldrum S., Osborne M., Malpas R.J.S., McElwain T. J. The development of high dose melphalan and of autologous hone marrow transplantation in the treatment of multiple myeloma: Royal Marsden and St. Bartholomew's Hospital studies. Hematological Oncology 1988; 6: 173–179
- Millar Bell B. C., Lakhani J. B. G., Ayliffe A., Selby M. J.P.J., McElwain T. J. A simple method for culturing myeloma cells from human bone marrow aspirates and peripheral blood in vitro. British Journal of Haematology 1988; 69: 197–203
- Millar Bell B. C., Maitland J. B. G., Zuiable J. A., Gore A., Selby M. E.P.J., McElwain T. J. In vitro studies of ways to overcome resistance to VAMP-high dose melphalan in the treatment of multiple myeloma. British Journal of Haematology 1989; 71: 213–222
- Bartl Frisch R., Patch-Moghadam B., Kettner A.G, Jaeger K., Sommerfeld W. Histologic classification and staging of multiple myeloma. A retrospective and prospective study of 674 cases. American Journal of Clinical Pathology 1987; 87: 342–355
- Bell Miliar J. B. G., Maitland B. C., Nandi J. A., Gore A.M., McElwain T. J. Increase in clonogenic tumour cells in hone marrow of patients with multiple myeloma treated with vincristine, doxorubicin and methylprednisolorie. Lancet 1988; ii: 931–933
- Millar Hudspith J. L.B.N., Blackett N. M. Reduced lethality in mice receiving a combined dose of cyclophosphamide and busulphan. British Journal of Cancer 1975; 32: 193–198
- Millar J. L., McElwain T. J. Combinations of cytotoxic agents that hake less than expected toxicity on normal tissues in mice. Fundamentals in Cancer Chemotherapy, Antibiotics and Chemotherapy, H. Schonfeld. S. Karger, Basel Switzerland 1978; 23: 271–282
- Evans Smith B. D.1.El., Clutterbuck R. D., Millar J. L. Normal tissue toxicity and antitumour experiments carried out in mice using high-dose cyclophosphamide. Cancer Treatment Reviews 1983; 10: 25–32
- Garman D, Center. M. S. Alteration in cell surface membranes in Chinese hamster lung cells resistant to adriamycin. Biochemical and Biophysical Research Communications 1982; 105: 157–163
- Kartner Shales N., Riordan S.J.K., Ling V. Daunorubicin-resistant Chinese hamster ovary cells expressing multidrug resistance and a cell-surface P-glycoprotein. Cancer Research 1983; 43: 4413–4419
- Hanada Hagiwara H., Nakajima K.T., Tsuruo T. Phosphorylation of the Mr 170,000 to 180,000 glycoprotein specific to multidrug-resistant tumor cells: effects' of verapamil, trifluoroperazine and phorbol esters. Cancer Research 1987; 47: 2860–2865
- Leonard MacLennan R. C. F., Smart I. C. M., VanHeyan Y.R.I., Cusich P. Light chain isotype associated suppression of normal plasma cell numbers in patients with multiple myeloma. International Journal of Cancer 1979; 24: 385–393